REFERENCES
- Van Bunk JA, Weisdorf D. Infections in recipients of blood and marrow transplantation. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. London: Churchill Livingstone, 2000: 3136–47.
- Reusser P, Current concepts and challenges in the pre-vention and treatment of viral infections in immuno-compromised cancer patients. Support Care Cancer 1998; 6: 39–45.
- Naesens L, Snoeck R, Andrei G, Balzarini J, Neyts J, De Clerq E. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential treatment of viral infec-tions. Antiviral Chem Chemother 1997; 8: 1–23.
- Safrin S, Cherrington J, Jaffe HS. Clinical Use of cido-fovir. Rev Med Virol 1997; 7: 145–56.
- Boeckh MJ, Ljungman P. Cytomegalovirus infection after BMT. In: Bowden RA, Ljungman P, Paya CV, eds. Transplant Infections. Philadelphia: Lippincott-Raven, 1998: 215–28.
- Green M, Michaels MG. Adenovirus, parvovirus B19 and papillomavirus. In: Bowden RA, Ljungman P, Paya CV, eds: Transplant Infections. Philadelphia: Lippincott-Raven, 1998: 287-94.
- Ljungman P, Lambertenghi Deliliers G, Platzbecker U, et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. Blood 2001; 97: 388–392.